SEC Form 4 · accession 0001209191-17-054195
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul L Jenkinson
Officer — Chief Financial Officer
Period of report
Sep 25, 2017
Accepted (ET)
Sep 27, 2017 · 9:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 25, 2017 | A | 2,500 | $0.00 | A | 10,410 | D | |
| Common Stock | Sep 25, 2017 | S | 948 | $179.6639 | D | 9,462 | D | |
| Common StockF3 | holding | — | — | — | 3,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on August 18, 2017.
- F2The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
- F3The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.